HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuji Sato Selected Research

shakuyaku-kanzoh-toh

1/2007Isoliquiritigenin, one of the antispasmodic principles of Glycyrrhiza ularensis roots, acts in the lower part of intestine.
5/2006Glycycoumarin from Glycyrrhizae Radix acts as a potent antispasmodic through inhibition of phosphodiesterase 3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuji Sato Research Topics

Disease

28Neoplasms (Cancer)
07/2022 - 05/2003
14Proteinuria
06/2020 - 06/2004
10Hypertension (High Blood Pressure)
06/2020 - 01/2005
8Chronic Kidney Failure (Chronic Renal Failure)
01/2020 - 01/2005
8IGA Glomerulonephritis (IGA Nephropathy)
02/2016 - 11/2004
7Stomach Neoplasms (Stomach Cancer)
07/2007 - 09/2002
6Glomerulonephritis
03/2020 - 12/2004
6Cardiovascular Diseases (Cardiovascular Disease)
11/2018 - 06/2012
5Nephrotic Syndrome (Syndrome, Nephrotic)
12/2021 - 01/2004
5Mucopolysaccharidosis II (Hunter Syndrome)
11/2021 - 01/2019
5Carcinoma (Carcinomatosis)
12/2018 - 01/2007
5Inflammation (Inflammations)
11/2018 - 05/2003
5Anaphylaxis (Anaphylactic Shock)
06/2010 - 07/2004
4Kidney Diseases (Kidney Disease)
03/2020 - 01/2016
4Infections
11/2018 - 01/2005
4Disease Progression
11/2017 - 01/2012
3Lysosomal Storage Diseases (Lysosomal Storage Disease)
06/2022 - 11/2021
3Mucopolysaccharidoses
06/2022 - 01/2020
3Weight Loss (Weight Reduction)
01/2022 - 03/2005
3Breast Neoplasms (Breast Cancer)
06/2021 - 06/2009
3Acute Kidney Injury (Acute Renal Failure)
01/2020 - 01/2009
3Myocardial Infarction
10/2016 - 07/2013
3Diabetes Mellitus
10/2016 - 01/2009
3Anemia
01/2014 - 01/2003
3Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
03/2012 - 06/2004
3Neoplasm Metastasis (Metastasis)
09/2010 - 02/2005
3Hypersensitivity (Allergy)
03/2006 - 09/2003
3Colonic Neoplasms (Colon Cancer)
02/2005 - 05/2003
2Medically Unexplained Symptoms
06/2022 - 11/2021
2Deglutition Disorders (Dysphagia)
01/2022 - 10/2021
2Diabetic Nephropathies (Diabetic Nephropathy)
05/2021 - 01/2020
2Tinnitus
03/2021 - 08/2018
2Fever (Fevers)
01/2021 - 06/2020
2Heart Failure
01/2021 - 06/2015
2Hyperglycemia
01/2020 - 12/2019
2Ketosis
01/2020 - 01/2020
2Weight Gain
01/2017 - 01/2016
2Atrial Fibrillation
10/2016 - 01/2016
2Dyslipidemias (Dyslipidemia)
07/2016 - 01/2005
2Lymphoma (Lymphomas)
02/2016 - 10/2005
2Hematuria
02/2016 - 11/2004
2Ovarian Neoplasms (Ovarian Cancer)
01/2016 - 05/2015
2Fibrosis (Cirrhosis)
07/2015 - 01/2003
2Major Depressive Disorder (Major Depressive Disorders)
04/2015 - 10/2014
2Unstable Angina
11/2013 - 07/2013
2Hemorrhage
07/2013 - 04/2013

Drug/Important Bio-Agent (IBA)

11Pharmaceutical PreparationsIBA
01/2022 - 07/2004
11CreatinineIBA
01/2020 - 01/2003
8Messenger RNA (mRNA)IBA
03/2020 - 10/2003
8SteroidsIBA
11/2017 - 01/2003
7Antihypertensive Agents (Antihypertensives)IBA
01/2020 - 10/2008
7Peptides (Polypeptides)IBA
05/2015 - 09/2003
6Biomarkers (Surrogate Marker)IBA
05/2021 - 02/2004
6Proteins (Proteins, Gene)FDA Link
11/2018 - 01/2005
5Prednisolone (Predate)FDA LinkGeneric
01/2020 - 01/2003
5Glucose (Dextrose)FDA LinkGeneric
10/2015 - 04/2012
5Fluorouracil (Carac)FDA LinkGeneric
09/2010 - 01/2004
4Adrenal Cortex Hormones (Corticosteroids)IBA
06/2020 - 01/2009
4Hemoglobins (Hemoglobin)IBA
01/2017 - 10/2012
4Histamine (Histamine Dihydrochloride)FDA Link
06/2010 - 07/2004
4Immunoglobulin G (IgG)IBA
07/2007 - 02/2004
4Macrophage Migration-Inhibitory FactorsIBA
07/2005 - 05/2003
3EnzymesIBA
06/2022 - 09/2007
3Transferrin Receptors (Transferrin Receptor)IBA
11/2021 - 01/2019
3GlycosaminoglycansIBA
11/2021 - 01/2019
3Warfarin (Coumadin)FDA LinkGeneric
01/2021 - 04/2012
3Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
03/2020 - 01/2006
3Tyrosine Kinase InhibitorsIBA
01/2019 - 07/2004
3Serum AlbuminIBA
01/2018 - 04/2012
3AntigensIBA
06/2010 - 01/2005
2Cyclosporine (Ciclosporin)FDA LinkGeneric
12/2021 - 06/2004
2AnticoagulantsIBA
12/2021 - 01/2016
24-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
03/2021 - 08/2018
2C-Reactive ProteinIBA
06/2020 - 01/2016
2LDL Lipoproteins (beta Lipoproteins)IBA
01/2020 - 02/2014
2Dasatinib (BMS 354825)FDA Link
01/2020 - 01/2019
2Rituximab (Mabthera)FDA Link
01/2020 - 01/2015
2Angiotensin IIIBA
11/2017 - 01/2012
2NPHS2 proteinIBA
09/2016 - 05/2009
2Triglycerides (Triacylglycerol)IBA
10/2015 - 02/2014
2Immunoglobulin A (IgA)IBA
07/2015 - 11/2004
2Antidepressive Agents (Antidepressants)IBA
10/2014 - 03/2014
2Dihydrotachysterol (AT 10)IBA
01/2014 - 01/2013
2candesartanIBA
12/2013 - 10/2008
2Angiotensin Receptor AntagonistsIBA
12/2013 - 10/2008
2Small Interfering RNA (siRNA)IBA
12/2013 - 02/2005
2Nifedipine (Adalat)FDA LinkGeneric
12/2013 - 10/2008
2ErbB Receptors (EGF Receptor)IBA
12/2013 - 07/2004

Therapy/Procedure

26Therapeutics
06/2022 - 01/2003
12Renal Dialysis (Hemodialysis)
01/2020 - 01/2005
7Drug Therapy (Chemotherapy)
01/2020 - 03/2005
5Percutaneous Coronary Intervention
06/2020 - 04/2013
5Tonsillectomy
02/2016 - 01/2005
4Long-Term Care
12/2022 - 10/2021
4Enzyme Replacement Therapy
06/2022 - 01/2020
3Aftercare (After-Treatment)
02/2016 - 01/2007
2Palliative Care (Palliative Therapy)
07/2022 - 02/2022
2Bite Force (Occlusal Forces)
03/2022 - 12/2021
2Nursing Care
01/2022 - 10/2021
2Oral Hygiene (Dental Hygiene)
01/2022 - 01/2018